COVID-19 Impact on Global Gene Knockdown Market Size, Status and Forecast 2020-2026

September 2020 | 134 pages | ID: C98C1C38C9E8EN
QYResearch

Abstracts

This report focuses on the global Gene Knockdown status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gene Knockdown development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Santa Cruz Biotechnology (US)
• OriGene (US)
• Sigma-Aldrich (US)
• Abnova (Taiwan)
• Agilent Technologies (US)
• Bio-Rad (US)
• Cell Signaling Technology (US)
• GeneCopoeia (US)
• siTOOLs Biotech (Germany)
• Novus Biologicals (US)
• EMD Millipore (US)
• BioVision (US)
• Creative Biomart (US)
• Selleck Chemicals (US)
• MyBioSource (US)
• Invitrogen (US)
• Qiagen (Germany)

Market segment by Type, the product can be split into

• siRNA
• shRNA
• Other

Market segment by Application, split into

• Medical
• Bioengineering
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Gene Knockdown status, future forecast, growth opportunity, key market and key players.
• To present the Gene Knockdown development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Gene Knockdown are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gene Knockdown Revenue
1.4 Market Analysis by Type
  1.4.1 Global Gene Knockdown Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 siRNA
  1.4.3 shRNA
  1.4.4 Other
1.5 Market by Application
  1.5.1 Global Gene Knockdown Market Share by Application: 2020 VS 2026
  1.5.2 Medical
  1.5.3 Bioengineering
  1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Gene Knockdown Industry Impact
  1.6.1 How the Covid-19 is Affecting the Gene Knockdown Industry
    1.6.1.1 Gene Knockdown Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Gene Knockdown Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Gene Knockdown Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Gene Knockdown Market Perspective (2015-2026)
2.2 Gene Knockdown Growth Trends by Regions
  2.2.1 Gene Knockdown Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Gene Knockdown Historic Market Share by Regions (2015-2020)
  2.2.3 Gene Knockdown Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Gene Knockdown Market Growth Strategy
  2.3.6 Primary Interviews with Key Gene Knockdown Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Gene Knockdown Players by Market Size
  3.1.1 Global Top Gene Knockdown Players by Revenue (2015-2020)
  3.1.2 Global Gene Knockdown Revenue Market Share by Players (2015-2020)
  3.1.3 Global Gene Knockdown Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Gene Knockdown Market Concentration Ratio
  3.2.1 Global Gene Knockdown Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Gene Knockdown Revenue in 2019
3.3 Gene Knockdown Key Players Head office and Area Served
3.4 Key Players Gene Knockdown Product Solution and Service
3.5 Date of Enter into Gene Knockdown Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Gene Knockdown Historic Market Size by Type (2015-2020)
4.2 Global Gene Knockdown Forecasted Market Size by Type (2021-2026)

5 GENE KNOCKDOWN BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Gene Knockdown Market Size by Application (2015-2020)
5.2 Global Gene Knockdown Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Gene Knockdown Market Size (2015-2020)
6.2 Gene Knockdown Key Players in North America (2019-2020)
6.3 North America Gene Knockdown Market Size by Type (2015-2020)
6.4 North America Gene Knockdown Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Gene Knockdown Market Size (2015-2020)
7.2 Gene Knockdown Key Players in Europe (2019-2020)
7.3 Europe Gene Knockdown Market Size by Type (2015-2020)
7.4 Europe Gene Knockdown Market Size by Application (2015-2020)

8 CHINA

8.1 China Gene Knockdown Market Size (2015-2020)
8.2 Gene Knockdown Key Players in China (2019-2020)
8.3 China Gene Knockdown Market Size by Type (2015-2020)
8.4 China Gene Knockdown Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Gene Knockdown Market Size (2015-2020)
9.2 Gene Knockdown Key Players in Japan (2019-2020)
9.3 Japan Gene Knockdown Market Size by Type (2015-2020)
9.4 Japan Gene Knockdown Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Gene Knockdown Market Size (2015-2020)
10.2 Gene Knockdown Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Gene Knockdown Market Size by Type (2015-2020)
10.4 Southeast Asia Gene Knockdown Market Size by Application (2015-2020)

11 INDIA

11.1 India Gene Knockdown Market Size (2015-2020)
11.2 Gene Knockdown Key Players in India (2019-2020)
11.3 India Gene Knockdown Market Size by Type (2015-2020)
11.4 India Gene Knockdown Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Gene Knockdown Market Size (2015-2020)
12.2 Gene Knockdown Key Players in Central & South America (2019-2020)
12.3 Central & South America Gene Knockdown Market Size by Type (2015-2020)
12.4 Central & South America Gene Knockdown Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Santa Cruz Biotechnology (US)
  13.1.1 Santa Cruz Biotechnology (US) Company Details
  13.1.2 Santa Cruz Biotechnology (US) Business Overview and Its Total Revenue
  13.1.3 Santa Cruz Biotechnology (US) Gene Knockdown Introduction
  13.1.4 Santa Cruz Biotechnology (US) Revenue in Gene Knockdown Business (2015-2020))
  13.1.5 Santa Cruz Biotechnology (US) Recent Development
13.2 OriGene (US)
  13.2.1 OriGene (US) Company Details
  13.2.2 OriGene (US) Business Overview and Its Total Revenue
  13.2.3 OriGene (US) Gene Knockdown Introduction
  13.2.4 OriGene (US) Revenue in Gene Knockdown Business (2015-2020)
  13.2.5 OriGene (US) Recent Development
13.3 Sigma-Aldrich (US)
  13.3.1 Sigma-Aldrich (US) Company Details
  13.3.2 Sigma-Aldrich (US) Business Overview and Its Total Revenue
  13.3.3 Sigma-Aldrich (US) Gene Knockdown Introduction
  13.3.4 Sigma-Aldrich (US) Revenue in Gene Knockdown Business (2015-2020)
  13.3.5 Sigma-Aldrich (US) Recent Development
13.4 Abnova (Taiwan)
  13.4.1 Abnova (Taiwan) Company Details
  13.4.2 Abnova (Taiwan) Business Overview and Its Total Revenue
  13.4.3 Abnova (Taiwan) Gene Knockdown Introduction
  13.4.4 Abnova (Taiwan) Revenue in Gene Knockdown Business (2015-2020)
  13.4.5 Abnova (Taiwan) Recent Development
13.5 Agilent Technologies (US)
  13.5.1 Agilent Technologies (US) Company Details
  13.5.2 Agilent Technologies (US) Business Overview and Its Total Revenue
  13.5.3 Agilent Technologies (US) Gene Knockdown Introduction
  13.5.4 Agilent Technologies (US) Revenue in Gene Knockdown Business (2015-2020)
  13.5.5 Agilent Technologies (US) Recent Development
13.6 Bio-Rad (US)
  13.6.1 Bio-Rad (US) Company Details
  13.6.2 Bio-Rad (US) Business Overview and Its Total Revenue
  13.6.3 Bio-Rad (US) Gene Knockdown Introduction
  13.6.4 Bio-Rad (US) Revenue in Gene Knockdown Business (2015-2020)
  13.6.5 Bio-Rad (US) Recent Development
13.7 Cell Signaling Technology (US)
  13.7.1 Cell Signaling Technology (US) Company Details
  13.7.2 Cell Signaling Technology (US) Business Overview and Its Total Revenue
  13.7.3 Cell Signaling Technology (US) Gene Knockdown Introduction
  13.7.4 Cell Signaling Technology (US) Revenue in Gene Knockdown Business (2015-2020)
  13.7.5 Cell Signaling Technology (US) Recent Development
13.8 GeneCopoeia (US)
  13.8.1 GeneCopoeia (US) Company Details
  13.8.2 GeneCopoeia (US) Business Overview and Its Total Revenue
  13.8.3 GeneCopoeia (US) Gene Knockdown Introduction
  13.8.4 GeneCopoeia (US) Revenue in Gene Knockdown Business (2015-2020)
  13.8.5 GeneCopoeia (US) Recent Development
13.9 siTOOLs Biotech (Germany)
  13.9.1 siTOOLs Biotech (Germany) Company Details
  13.9.2 siTOOLs Biotech (Germany) Business Overview and Its Total Revenue
  13.9.3 siTOOLs Biotech (Germany) Gene Knockdown Introduction
  13.9.4 siTOOLs Biotech (Germany) Revenue in Gene Knockdown Business (2015-2020)
  13.9.5 siTOOLs Biotech (Germany) Recent Development
13.10 Novus Biologicals (US)
  13.10.1 Novus Biologicals (US) Company Details
  13.10.2 Novus Biologicals (US) Business Overview and Its Total Revenue
  13.10.3 Novus Biologicals (US) Gene Knockdown Introduction
  13.10.4 Novus Biologicals (US) Revenue in Gene Knockdown Business (2015-2020)
  13.10.5 Novus Biologicals (US) Recent Development
13.11 EMD Millipore (US)
  10.11.1 EMD Millipore (US) Company Details
  10.11.2 EMD Millipore (US) Business Overview and Its Total Revenue
  10.11.3 EMD Millipore (US) Gene Knockdown Introduction
  10.11.4 EMD Millipore (US) Revenue in Gene Knockdown Business (2015-2020)
  10.11.5 EMD Millipore (US) Recent Development
13.12 BioVision (US)
  10.12.1 BioVision (US) Company Details
  10.12.2 BioVision (US) Business Overview and Its Total Revenue
  10.12.3 BioVision (US) Gene Knockdown Introduction
  10.12.4 BioVision (US) Revenue in Gene Knockdown Business (2015-2020)
  10.12.5 BioVision (US) Recent Development
13.13 Creative Biomart (US)
  10.13.1 Creative Biomart (US) Company Details
  10.13.2 Creative Biomart (US) Business Overview and Its Total Revenue
  10.13.3 Creative Biomart (US) Gene Knockdown Introduction
  10.13.4 Creative Biomart (US) Revenue in Gene Knockdown Business (2015-2020)
  10.13.5 Creative Biomart (US) Recent Development
13.14 Selleck Chemicals (US)
  10.14.1 Selleck Chemicals (US) Company Details
  10.14.2 Selleck Chemicals (US) Business Overview and Its Total Revenue
  10.14.3 Selleck Chemicals (US) Gene Knockdown Introduction
  10.14.4 Selleck Chemicals (US) Revenue in Gene Knockdown Business (2015-2020)
  10.14.5 Selleck Chemicals (US) Recent Development
13.15 MyBioSource (US)
  10.15.1 MyBioSource (US) Company Details
  10.15.2 MyBioSource (US) Business Overview and Its Total Revenue
  10.15.3 MyBioSource (US) Gene Knockdown Introduction
  10.15.4 MyBioSource (US) Revenue in Gene Knockdown Business (2015-2020)
  10.15.5 MyBioSource (US) Recent Development
13.16 Invitrogen (US)
  10.16.1 Invitrogen (US) Company Details
  10.16.2 Invitrogen (US) Business Overview and Its Total Revenue
  10.16.3 Invitrogen (US) Gene Knockdown Introduction
  10.16.4 Invitrogen (US) Revenue in Gene Knockdown Business (2015-2020)
  10.16.5 Invitrogen (US) Recent Development
13.17 Qiagen (Germany)
  10.17.1 Qiagen (Germany) Company Details
  10.17.2 Qiagen (Germany) Business Overview and Its Total Revenue
  10.17.3 Qiagen (Germany) Gene Knockdown Introduction
  10.17.4 Qiagen (Germany) Revenue in Gene Knockdown Business (2015-2020)
  10.17.5 Qiagen (Germany) Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Gene Knockdown Key Market Segments
Table 2. Key Players Covered: Ranking by Gene Knockdown Revenue
Table 3. Ranking of Global Top Gene Knockdown Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Gene Knockdown Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of siRNA
Table 6. Key Players of shRNA
Table 7. Key Players of Other
Table 8. COVID-19 Impact Global Market: (Four Gene Knockdown Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Gene Knockdown Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Gene Knockdown Players to Combat Covid-19 Impact
Table 13. Global Gene Knockdown Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Gene Knockdown Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Gene Knockdown Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Gene Knockdown Market Share by Regions (2015-2020)
Table 17. Global Gene Knockdown Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Gene Knockdown Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Gene Knockdown Market Growth Strategy
Table 23. Main Points Interviewed from Key Gene Knockdown Players
Table 24. Global Gene Knockdown Revenue by Players (2015-2020) (Million US$)
Table 25. Global Gene Knockdown Market Share by Players (2015-2020)
Table 26. Global Top Gene Knockdown Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Knockdown as of 2019)
Table 27. Global Gene Knockdown by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Gene Knockdown Product Solution and Service
Table 30. Date of Enter into Gene Knockdown Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Gene Knockdown Market Size by Type (2015-2020) (Million US$)
Table 33. Global Gene Knockdown Market Size Share by Type (2015-2020)
Table 34. Global Gene Knockdown Revenue Market Share by Type (2021-2026)
Table 35. Global Gene Knockdown Market Size Share by Application (2015-2020)
Table 36. Global Gene Knockdown Market Size by Application (2015-2020) (Million US$)
Table 37. Global Gene Knockdown Market Size Share by Application (2021-2026)
Table 38. North America Key Players Gene Knockdown Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Gene Knockdown Market Share (2019-2020)
Table 40. North America Gene Knockdown Market Size by Type (2015-2020) (Million US$)
Table 41. North America Gene Knockdown Market Share by Type (2015-2020)
Table 42. North America Gene Knockdown Market Size by Application (2015-2020) (Million US$)
Table 43. North America Gene Knockdown Market Share by Application (2015-2020)
Table 44. Europe Key Players Gene Knockdown Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Gene Knockdown Market Share (2019-2020)
Table 46. Europe Gene Knockdown Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Gene Knockdown Market Share by Type (2015-2020)
Table 48. Europe Gene Knockdown Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Gene Knockdown Market Share by Application (2015-2020)
Table 50. China Key Players Gene Knockdown Revenue (2019-2020) (Million US$)
Table 51. China Key Players Gene Knockdown Market Share (2019-2020)
Table 52. China Gene Knockdown Market Size by Type (2015-2020) (Million US$)
Table 53. China Gene Knockdown Market Share by Type (2015-2020)
Table 54. China Gene Knockdown Market Size by Application (2015-2020) (Million US$)
Table 55. China Gene Knockdown Market Share by Application (2015-2020)
Table 56. Japan Key Players Gene Knockdown Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Gene Knockdown Market Share (2019-2020)
Table 58. Japan Gene Knockdown Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Gene Knockdown Market Share by Type (2015-2020)
Table 60. Japan Gene Knockdown Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Gene Knockdown Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Gene Knockdown Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Gene Knockdown Market Share (2019-2020)
Table 64. Southeast Asia Gene Knockdown Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Gene Knockdown Market Share by Type (2015-2020)
Table 66. Southeast Asia Gene Knockdown Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Gene Knockdown Market Share by Application (2015-2020)
Table 68. India Key Players Gene Knockdown Revenue (2019-2020) (Million US$)
Table 69. India Key Players Gene Knockdown Market Share (2019-2020)
Table 70. India Gene Knockdown Market Size by Type (2015-2020) (Million US$)
Table 71. India Gene Knockdown Market Share by Type (2015-2020)
Table 72. India Gene Knockdown Market Size by Application (2015-2020) (Million US$)
Table 73. India Gene Knockdown Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Gene Knockdown Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Gene Knockdown Market Share (2019-2020)
Table 76. Central & South America Gene Knockdown Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Gene Knockdown Market Share by Type (2015-2020)
Table 78. Central & South America Gene Knockdown Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Gene Knockdown Market Share by Application (2015-2020)
Table 80. Santa Cruz Biotechnology (US) Company Details
Table 81. Santa Cruz Biotechnology (US) Business Overview
Table 82. Santa Cruz Biotechnology (US) Product
Table 83. Santa Cruz Biotechnology (US) Revenue in Gene Knockdown Business (2015-2020) (Million US$)
Table 84. Santa Cruz Biotechnology (US) Recent Development
Table 85. OriGene (US) Company Details
Table 86. OriGene (US) Business Overview
Table 87. OriGene (US) Product
Table 88. OriGene (US) Revenue in Gene Knockdown Business (2015-2020) (Million US$)
Table 89. OriGene (US) Recent Development
Table 90. Sigma-Aldrich (US) Company Details
Table 91. Sigma-Aldrich (US) Business Overview
Table 92. Sigma-Aldrich (US) Product
Table 93. Sigma-Aldrich (US) Revenue in Gene Knockdown Business (2015-2020) (Million US$)
Table 94. Sigma-Aldrich (US) Recent Development
Table 95. Abnova (Taiwan) Company Details
Table 96. Abnova (Taiwan) Business Overview
Table 97. Abnova (Taiwan) Product
Table 98. Abnova (Taiwan) Revenue in Gene Knockdown Business (2015-2020) (Million US$)
Table 99. Abnova (Taiwan) Recent Development
Table 100. Agilent Technologies (US) Company Details
Table 101. Agilent Technologies (US) Business Overview
Table 102. Agilent Technologies (US) Product
Table 103. Agilent Technologies (US) Revenue in Gene Knockdown Business (2015-2020) (Million US$)
Table 104. Agilent Technologies (US) Recent Development
Table 105. Bio-Rad (US) Company Details
Table 106. Bio-Rad (US) Business Overview
Table 107. Bio-Rad (US) Product
Table 108. Bio-Rad (US) Revenue in Gene Knockdown Business (2015-2020) (Million US$)
Table 109. Bio-Rad (US) Recent Development
Table 110. Cell Signaling Technology (US) Company Details
Table 111. Cell Signaling Technology (US) Business Overview
Table 112. Cell Signaling Technology (US) Product
Table 113. Cell Signaling Technology (US) Revenue in Gene Knockdown Business (2015-2020) (Million US$)
Table 114. Cell Signaling Technology (US) Recent Development
Table 115. GeneCopoeia (US) Business Overview
Table 116. GeneCopoeia (US) Product
Table 117. GeneCopoeia (US) Company Details
Table 118. GeneCopoeia (US) Revenue in Gene Knockdown Business (2015-2020) (Million US$)
Table 119. GeneCopoeia (US) Recent Development
Table 120. siTOOLs Biotech (Germany) Company Details
Table 121. siTOOLs Biotech (Germany) Business Overview
Table 122. siTOOLs Biotech (Germany) Product
Table 123. siTOOLs Biotech (Germany) Revenue in Gene Knockdown Business (2015-2020) (Million US$)
Table 124. siTOOLs Biotech (Germany) Recent Development
Table 125. Novus Biologicals (US) Company Details
Table 126. Novus Biologicals (US) Business Overview
Table 127. Novus Biologicals (US) Product
Table 128. Novus Biologicals (US) Revenue in Gene Knockdown Business (2015-2020) (Million US$)
Table 129. Novus Biologicals (US) Recent Development
Table 130. EMD Millipore (US) Company Details
Table 131. EMD Millipore (US) Business Overview
Table 132. EMD Millipore (US) Product
Table 133. EMD Millipore (US) Revenue in Gene Knockdown Business (2015-2020) (Million US$)
Table 134. EMD Millipore (US) Recent Development
Table 135. BioVision (US) Company Details
Table 136. BioVision (US) Business Overview
Table 137. BioVision (US) Product
Table 138. BioVision (US) Revenue in Gene Knockdown Business (2015-2020) (Million US$)
Table 139. BioVision (US) Recent Development
Table 140. Creative Biomart (US) Company Details
Table 141. Creative Biomart (US) Business Overview
Table 142. Creative Biomart (US) Product
Table 143. Creative Biomart (US) Revenue in Gene Knockdown Business (2015-2020) (Million US$)
Table 144. Creative Biomart (US) Recent Development
Table 145. Selleck Chemicals (US) Company Details
Table 146. Selleck Chemicals (US) Business Overview
Table 147. Selleck Chemicals (US) Product
Table 148. Selleck Chemicals (US) Revenue in Gene Knockdown Business (2015-2020) (Million US$)
Table 149. Selleck Chemicals (US) Recent Development
Table 150. MyBioSource (US) Company Details
Table 151. MyBioSource (US) Business Overview
Table 152. MyBioSource (US) Product
Table 153. MyBioSource (US) Revenue in Gene Knockdown Business (2015-2020) (Million US$)
Table 154. MyBioSource (US) Recent Development
Table 155. Invitrogen (US) Company Details
Table 156. Invitrogen (US) Business Overview
Table 157. Invitrogen (US) Product
Table 158. Invitrogen (US) Revenue in Gene Knockdown Business (2015-2020) (Million US$)
Table 159. Invitrogen (US) Recent Development
Table 160. Qiagen (Germany) Company Details
Table 161. Qiagen (Germany) Business Overview
Table 162. Qiagen (Germany) Product
Table 163. Qiagen (Germany) Revenue in Gene Knockdown Business (2015-2020) (Million US$)
Table 164. Qiagen (Germany) Recent Development
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Gene Knockdown Market Share by Type: 2020 VS 2026
Figure 2. siRNA Features
Figure 3. shRNA Features
Figure 4. Other Features
Figure 5. Global Gene Knockdown Market Share by Application: 2020 VS 2026
Figure 6. Medical Case Studies
Figure 7. Bioengineering Case Studies
Figure 8. Other Case Studies
Figure 9. Gene Knockdown Report Years Considered
Figure 10. Global Gene Knockdown Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Gene Knockdown Market Share by Regions: 2020 VS 2026
Figure 12. Global Gene Knockdown Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Gene Knockdown Market Share by Players in 2019
Figure 15. Global Top Gene Knockdown Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Knockdown as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Gene Knockdown Revenue in 2019
Figure 17. North America Gene Knockdown Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Gene Knockdown Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Gene Knockdown Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Gene Knockdown Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Gene Knockdown Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Gene Knockdown Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Gene Knockdown Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Santa Cruz Biotechnology (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Santa Cruz Biotechnology (US) Revenue Growth Rate in Gene Knockdown Business (2015-2020)
Figure 26. OriGene (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. OriGene (US) Revenue Growth Rate in Gene Knockdown Business (2015-2020)
Figure 28. Sigma-Aldrich (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Sigma-Aldrich (US) Revenue Growth Rate in Gene Knockdown Business (2015-2020)
Figure 30. Abnova (Taiwan) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Abnova (Taiwan) Revenue Growth Rate in Gene Knockdown Business (2015-2020)
Figure 32. Agilent Technologies (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Agilent Technologies (US) Revenue Growth Rate in Gene Knockdown Business (2015-2020)
Figure 34. Bio-Rad (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Bio-Rad (US) Revenue Growth Rate in Gene Knockdown Business (2015-2020)
Figure 36. Cell Signaling Technology (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Cell Signaling Technology (US) Revenue Growth Rate in Gene Knockdown Business (2015-2020)
Figure 38. GeneCopoeia (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. GeneCopoeia (US) Revenue Growth Rate in Gene Knockdown Business (2015-2020)
Figure 40. siTOOLs Biotech (Germany) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. siTOOLs Biotech (Germany) Revenue Growth Rate in Gene Knockdown Business (2015-2020)
Figure 42. Novus Biologicals (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Novus Biologicals (US) Revenue Growth Rate in Gene Knockdown Business (2015-2020)
Figure 44. EMD Millipore (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. EMD Millipore (US) Revenue Growth Rate in Gene Knockdown Business (2015-2020)
Figure 46. BioVision (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. BioVision (US) Revenue Growth Rate in Gene Knockdown Business (2015-2020)
Figure 48. Creative Biomart (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Creative Biomart (US) Revenue Growth Rate in Gene Knockdown Business (2015-2020)
Figure 50. Selleck Chemicals (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Selleck Chemicals (US) Revenue Growth Rate in Gene Knockdown Business (2015-2020)
Figure 52. MyBioSource (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. MyBioSource (US) Revenue Growth Rate in Gene Knockdown Business (2015-2020)
Figure 54. Invitrogen (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Invitrogen (US) Revenue Growth Rate in Gene Knockdown Business (2015-2020)
Figure 56. Qiagen (Germany) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Qiagen (Germany) Revenue Growth Rate in Gene Knockdown Business (2015-2020)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed